A5072904746- Head and Neck Surgical Oncology
- Meningioma and schwannoma management
- Hearing Loss and Rehabilitation
- Head and Neck Cancer Studies
- Olfactory and Sensory Function Studies
- Ear Surgery and Otitis Media
- Ear and Head Tumors
- Advanced Chemical Sensor Technologies
- Neurofibromatosis and Schwannoma Cases
- Hearing, Cochlea, Tinnitus, Genetics
- Salivary Gland Tumors Diagnosis and Treatment
- Long-Term Effects of COVID-19
- Bone Tumor Diagnosis and Treatments
- Oral and Maxillofacial Pathology
- Sinusitis and nasal conditions
- Cerebral Venous Sinus Thrombosis
- Inflammatory Biomarkers in Disease Prognosis
- Biochemical Analysis and Sensing Techniques
- Vestibular and auditory disorders
- Facial Nerve Paralysis Treatment and Research
- Cerebrospinal fluid and hydrocephalus
- Tracheal and airway disorders
- COVID-19 Clinical Research Studies
- Pituitary Gland Disorders and Treatments
- Voice and Speech Disorders
Cambridge University Hospitals NHS Foundation Trust
2019-2025
Addenbrooke's Hospital
2018-2025
University of Cambridge
2018-2025
Bridge University
2019-2025
University of Padua
2014-2024
Guy's Hospital
2020-2022
University of Trieste
2020-2022
University of Sassari
2022
Azienda Ospedaliero Universitaria di Sassari
2022
ELSA
2022
Michael Eliezer, MD; Charlotte Hautefort, Anne-Laure Hamel, Benjamin Verillaud, Philippe Herman, MD, PhD; Emmanuel Houdart, Corinne Eloit, MD
<h3>Importance</h3> An altered sense of smell and taste has been reported to be associated with coronavirus disease 2019 (COVID-19). To understand the evolution these symptoms during course is important identify patients persistent loss or estimate impact severe acute respiratory syndrome 2 (SARS-CoV-2) infection on burden olfactory gustative dysfunctions. <h3>Objective</h3> evaluate in a case series mildly symptomatic SARS-CoV-2 infection. <h3>Design, Setting, Participants</h3> This...
Abstract This study prospectively assessed the 6-month prevalence of self-reported and psychophysically measured olfactory dysfunction in subjects with mild-to-moderate COVID-19. Self-reported smell or taste impairment was evaluated by SNOT-22 at diagnosis, 4-week, 8-week, 6-month. At 6 months from psychophysical evaluation function also performed using 34-item culturally adapted University Pennsylvania Smell Identification Test (CA-UPSIT). 145 completed both subjective evaluation. According...
Severe acute respiratory syndrome-coronavirus-2 (SARS-CoV-2) infection can cause a wide array of symptoms ranging from mild to severe or fatal forms coronavirus disease 2019 (COVID-19).1 Furthermore, it has been observed that in proportion patients variable range may persist for long time.2 An increasing number studies have focused on COVID, but they mainly concentrated previously hospitalized COVID-19 reporting up 6-months after illness.3, 4 The main aim this study was evaluate the...
Abstract Background The aim of this study was to estimate the prevalence self‐reported chemosensory dysfunction in a cohort subjects who developed mild‐to‐moderate coronavirus disease 2019 (COVID‐19) period from January 17, 2022, February 4, 2022 (Omicron proxy period) and compared that with historical series patients testing positive for severe acute respiratory syndrome–coronavirus‐2 (SARS‐CoV‐2) infection between March April, 2020 (comparator period). Methods Prospective based on 22‐item...
The aim of the present study was to estimate 1 year prevalence and recovery rate self-reported chemosensory dysfunction in a series subjects with previous mild-to-moderate symptomatic COVID-19.Prospective based on SNOT-22, item "sense smell or taste" additional outcomes.268/315 patients (85.1%) completing survey at baseline also completed follow-up interview. 12 months COVID-19 associated 21.3% (95% CI 16.5-26.7%). Of 187 who complained baseline, 130 (69.5%; 95% 62.4-76.0%) reported complete...
Using an age and gender matched-pair case-control study, we aimed to estimate the long-term prevalence of psychophysical olfactory, gustatory , chemesthesis impairment at least one year after SARS-CoV-2 infection considering background chemosensory dysfunction in non-COVID-19 population.This case-controlled study included 100 patients who were home-isolated for mildly symptomatic COVID-19 between March April 2020. One control regularly tested always negative was matched each case according...
The aim of this study was to psychophysically evaluate the prevalence smell and taste dysfunction 2 years after mildly symptomatic severe acute respiratory syndrome-coronavirus-2 (SARS-CoV-2) infection compared that observed at 1-year follow-up while considering background chemosensory in no-coronavirus disease 2019 (COVID-19) population.This is a prospective case-control on 93 patients with polymerase chain reaction (PCR)-positive SARS-CoV-2 matched controls. Self-reported olfactory...
To estimate the prevalence of smell or taste impairment in household contacts mildly symptomatic home-isolated SARS-CoV-2-positive patients.Cross-sectional study based on ad hoc questions.Of 214 COVID-19 patients managed at home under self-isolation, 179 reported to have least one contact, with total number no participants being 296. Among 175 not tested for SARS-CoV-2 infection, 67 (38.3%) had compatible symptoms, 39 (22.3%) loss 7 (4.0%) having absence other symptoms. The was 1.5% negative...
There is mounting evidence that a new onset of altered sense smell or taste related to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. In order allow patients recognize symptoms indicative SARS-CoV-2 infection and self-isolate at the earliest opportunity, self-reported loss have greater value in controlling disease transmission than psychophysical testing, which not widely available outside highly specialized clinics.
Abstract Background Radiation treatment of benign tumors in tumor predisposition syndromes is controversial, but short-term studies from centers suggest safety despite apparent radiation-associated malignancy being reported. We determined whether radiation NF2-related schwannomatosis patients associated with increased rates subsequent (M)/malignant progression (MP). Methods All UK NF2 were eligible if they had a clinical/molecular diagnosis. Cases treated for tumors. Controls matched...
Background: This study examines the management and outcomes of large paranasal sinus osteomas (PSO), especially those abutting or encasing critical structures skull base orbit. Methodology: A multicentric retrospective analysis was conducted between June 2007 September 2023. The included surgically treated (regardless type approach chosen) PSO, exceeding 3 cm in diameter and/or located anatomical areas. An performed to assess association relationships, size, presence residual disease,...